Does MITOXANTRONE Cause Thrombotic microangiopathy? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Thrombotic microangiopathy have been filed in association with MITOXANTRONE (mitoXANTRONE). This represents 0.1% of all adverse event reports for MITOXANTRONE.
6
Reports of Thrombotic microangiopathy with MITOXANTRONE
0.1%
of all MITOXANTRONE reports
5
Deaths
2
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From MITOXANTRONE?
Of the 6 reports, 5 (83.3%) resulted in death, 2 (33.3%) required hospitalization.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOXANTRONE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does MITOXANTRONE Cause?
Febrile neutropenia (668)
Off label use (368)
Neutropenia (296)
Drug ineffective (293)
Thrombocytopenia (256)
Sepsis (240)
Pyrexia (214)
Product use in unapproved indication (177)
Disease progression (173)
Acute myeloid leukaemia (167)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which MITOXANTRONE Alternatives Have Lower Thrombotic microangiopathy Risk?
MITOXANTRONE vs MITRAGYNINE\HERBALS
MITOXANTRONE vs MIZORIBINE
MITOXANTRONE vs MOBOCERTINIB
MITOXANTRONE vs MOCLOBEMIDE
MITOXANTRONE vs MODAFINIL